Featured Stories
Seno Medical Presents Results of MAESTRO Study at EUSOBI
AuntMinnieEurope.com – September 27, 2016
Breast imaging developer Seno Medical Instruments announced interim results from its MAESTRO study at last week’s European Society of Breast Imaging (EUSOBI) meeting in Paris. The results from the study demonstrate the potential…
New Interim Results Support Imagio™ Opto-Acoustic (OA) Breast Imaging System’s Potential to Reduce Negative Biopsies
HealthCareBusiness Daily News (via PR Newswire) – Sepetmber 24, 2014
SAN ANTONIO, Sept. 24, 2016 /PRNewswire/ — Seno Medical Instruments, Inc. (Seno Medical), the company pioneering the development of opto-acoustic technology as a tool to improve the process of diagnosing breast cancer…
Seno Medical Reports Positive Interim Data from Maestro Study of Breast Imaging System
Medical Device Network Market & Customer Insight – September 26, 2016
US-based medical imaging company Seno Medical has reported positive interim results from its MAESTRO study of Imagio opto-acoustic (OA) a breast imaging system used to detect breast cancer…
New Interim Results Support Imagio Opto-Acoustic (OA) Breast Imaging System’s Potential to Reduce Negative Biopsies
BioSpace (via PR Newswire) – September 26, 2016
Seno Medical Instruments, Inc. (Seno Medical), the company pioneering the development of opto-acoustic technology as a tool to improve the process of diagnosing breast cancer, announced today…
